INTRODUCTION
Gill-associated virus (GAV) is an enveloped, rod-shaped nidovirus that occurs commonly in wild and farmed black tiger shrimp (Penaeus monodon) in Australia and South-east Asia and has been linked to disease outbreaks in farmed shrimp that have been described as mid-crop mortality syndrome (MCMS) (Callinan et al., 2003; Spann et al., 1997) . It is one of six known genotypes in a complex of viruses infecting P. monodon shrimp that also includes the highly virulent yellow head virus (YHV) and four other genotypes that have been detected only in healthy shrimp (Wijegoonawardane et al., 2008) . These viruses are classified together as the species Gill-associated virus in the genus Okavirus of the family Roniviridae (Walker et al., 2005) . The 26 235 nt positive-sense ssRNA GAV genome ( Fig. 1) contains a large replicase gene comprising two long reading frames (ORF1a/ORF1b) encoding protease, RNA-dependent RNA polymerase (RdRp), helicase and other conserved enzymic domains, a nucleoprotein gene (ORF2), a polyglycoprotein gene (ORF3) encoding the two envelope glycoproteins (gp64 and gp116) and a small pseudogene (ORF4) Cowley & Walker, 2002; Jitrapakdee et al., 2003) . Natural genetic recombination between GAV and other genotypes in the yellow head complex has been reported (Wijegoonawardane et al., 2009) .
Mourilyan virus (MoV) also occurs commonly in healthy wild and farmed P. monodon shrimp in Australia (Cowley et al., 2005a) and has been linked to disease outbreaks in farmed kuruma shrimp (Penaeus japonicus) in which GAV does not naturally occur (Sellars et al., 2006; Walker et al., 2001) . MoV is an enveloped negative-sense ssRNA virus containing four genome segments that have not yet been taxonomically classified, but shares a similar particle morphology and significant sequence homology with bunyaviruses (Cowley et al., 2005b) . The MoV genome ( Fig. 1 ) comprises the L RNA segment encoding the RdRp, the M segment encoding two transmembrane glycoproteins (G1 and G2), and two small segments (S1 and S2) encoding, respectively, the nucleoprotein (N) and a small non-structural protein (NSs2) of yet unidentified function (Cowley et al., 2005b) . In several bunyaviruses, small nonstructural proteins encoded in the M segment (NSm) and S segment (NSs) have been shown to block host defensive responses, including post-transcriptional gene silencing by RNA interference (RNAi) (Garcia et al., 2006; Soldan et al., 2005; Takeda et al., 2002) .
Due to the very high prevalence of low-level persistent infections in healthy populations, most P. monodon shrimp collected in Australia show evidence of infection with both GAV and MoV . Indeed, in moribund shrimp collected from MCMS outbreaks, high infections loads of both viruses are common. In P. monodon injected with tissue extracts from diseased shrimp, mortalities occur in conjunction with elevated infection loads of both GAV and MoV, and each virus displays similar tissue distribution (Cowley et al., 2005b; Spann et al., 2003) . Preexisting GAV and MoV infections in healthy P. monodon shrimp used for experimental infections have also confounded interpretation of bioassays. Furthermore, as no continuous cell lines are available for propagation of shrimp viruses, plaque purification methods cannot be used to separate GAV and MoV and there is currently no effective physical method for differential purification of the viruses from shrimp tissues. It has been difficult, therefore, to determine the respective roles of GAV and MoV in MCMS, and whether high-level infection with each virus is needed to induce mortalities in farmed P. monodon.
In this study, the pathogenicity of GAV and MoV in P. monodon shrimp was examined by using RNAi to selectively block the replication of each virus. The data indicate that, in co-infected shrimp, mortalities are due to GAV and that high levels of MoV infection can be tolerated in the absence of disease.
RESULTS
Viral genetic loads in experimentally infected P. monodon shrimp Two mixed virus inocula ( # 04 and # 06) were prepared by passage of infected shrimp tissue in healthy P. monodon. Each inoculum was prepared from the same cephalothorax tissue extract that was known to be infected with both GAV and MoV and had originated from moribund P. monodon collected during an MCMS outbreak in South-east Queensland in 1996 (Spann et al., 1997) . Viral genetic loads in each stock were determined by quantitative realtime RT-PCR (qRT-PCR). In stock # 04, the MoV genetic load (2.0610 8 RNA copies ml 21 ) was approximately 200-fold higher than that of GAV (9.9610 5 RNA copies ml 21 ) (Table 1) ; in stock # 06, the GAV genetic load (2.0610 7 RNA copies ml
21
) was approximately fivefold higher than that of MoV (3.6610 6 RNA copies ml 21 ) ( Table 2) . In the positive-sense ssRNA GAV genome, the locations of ORF1a, ORF1b, ORF2 (encoding nucleoprotein p20), ORF3 (encoding triple-membrane-spanning p25 and envelope glycoproteins gp116 and gp64), possible ORF4, and the ribosomal frame-shift site (RFS) are shown. In the negativesegmented ssRNA MoV genome, L RNA (encoding the polymerase), M RNA (encoding envelope glycoproteins G1 and G2), S1 RNA (encoding the nucleoprotein N) and S2 RNA (encoding the NSs2 protein) are shown. The locations of dsRNA probes employed for gene knockdown are also shown.
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In the first bioassay, duplicate groups of 20 healthy juvenile P. monodon shrimp were injected with undiluted inoculum # 04. Mortalities commenced at 4 days post-infection (p.i.) and survival stabilized at 10 % at 15 days p.i. (Fig. 2a) In a second bioassay, duplicate groups of 20 healthy juvenile P. monodon were injected with neat and 2-, 4-, 10-, 20-and 100-fold dilutions of inoculum #06 (Fig. 2b) .
Injection with the undiluted stock resulted in mortalities commencing at 5 days p.i. and 100 % cumulative mortality at 18 days p.i. A similar mortality curve was obtained at a twofold dilution, but at higher inoculum dilutions the onset of mortalities was delayed until 9-13 days p.i. and there was a progressive decrease in cumulative mortalities. No mortalities occurred in saline-injected control groups during the 19 day duration of the bioassay. Viral genetic loads in gill tissue were determined by qRT-PCR at 3, 6 and 9 days p.i. In saline-injected control shrimp, the mean GAV (0.84-2.88610 5 RNA copies ng 21 total RNA) and MoV (1.21-1.57610 5 RNA copies ng 21 total RNA) genetic loads were similar and varied little over time, indicating stable, low-grade pre-existing infections. In shrimp injected with undiluted inoculum # 06, mean genetic loads of 9 RNA copies ng 21 total RNA) and 8 RNA copies ng 21 total RNA) were substantially higher and increased progressively over time. Reflecting the relative viral genetic loads in the inoculum, the mean genetic load of GAV was significantly higher than MoV at each time point (Table 2) .
RNAi inhibition of GAV infection
Groups of 20 healthy juvenile P. monodon shrimp were injected with undiluted inoculum #04 and then injected immediately with dsRNA corresponding to sequences in (i) the firefly luciferase gene (dsRNA-luc), (ii) the GAV RdRp domain (dsRNA-GAVRdRp), (iii) the GAV helicase DRNA copies±SD ng 21 total RNA. domain (dsRNA-GAVhel) or (iv) a mixture of dsRNAGAVhel and dsRNA corresponding to sequences in MoV RNA segment S2 encoding NSs2 (dsRNA-MoVNSs2). The genome locations of GAV and MoV dsRNAs are shown in Fig. 1 . Cumulative mortalities were recorded for 22 days, and at 3 days p.i. haemolymph was collected from three shrimp from each group and mean GAV and MoV genetic loads were determined by qRT-PCR.
As shown in Fig. 3 (a), injection with dsRNA-GAVRdRp or dsRNA-GAVhel resulted in a significant (P,0.0001) delay of mortalities, with median survival increasing from 6 to 12 days p.i. compared with the untreated control group. Median survival in the group treated with non-specific dsRNA (dsRNA-luc) was not significantly different from untreated controls. Median survival of the group simultaneously treated with dsRNA-GAVhel and dsRNAMoVNSs2 was not significantly different from treatment with dsRNA-GAVhel or dsRNA-RdRp alone. As shown in Fig. 3 (b), mean GAV genetic loads in haemocytes at 3 days p.i. were reduced significantly (P,0.01) in the groups treated with dsRNA-GAVhel or dsRNA-RdRp compared with the untreated control group. In the group treated with dsRNA-GAVhel and dsRNA-MoVNSs2, the mean GAV genetic load was also reduced significantly compared with the untreated control group (P,0.05), but not compared to the group treated with dsRNA-helicase alone (P.0.05).
In the group treated with dsRNA-luc, the GAV genetic load was reduced slightly compared to the control group, but the difference was not statistically significant (P.0.05). As shown in Fig. 3(c) , there was no significant difference in the MoV genetic loads between the different treatments (P.0.05), including treatment with a combination of dsRNA-GAVhel and dsRNA-MoVNSs2. Similar results were observed in an independent duplicate experiment (data not shown).
To determine if dsRNA-RdRp-induced inhibition of GAV infection was more effective at a lower infection dose, groups of 20 healthy juvenile P. monodon shrimp were injected with stock inoculum #06 diluted 1 : 3 to achieve a dose approximating the LD 50 (as assessed from the titration shown in Fig. 2 ). Shrimp were then immediately injected with dsRNA-GAVRdRp or dsRNA-luc and (b) GAV genetic loads determined by qRT-PCR in P. monodon shrimp groups at 3 days p.i. following injection with 0.9 % NaCl or undiluted virus inoculum # 04 followed immediately by injection of various dsRNAs as shown. Haemolymph pooled from three shrimp was used as a source of RNA and data are expressed as GAV RNA copies ng "1 total RNA. Bars indicate SEM between samples from the duplicate groups. (c) MoV genetic loads determined by qRT-PCR in P. monodon shrimp groups at 3 days p.i. following injection with 0.9 % NaCl or undiluted virus inoculum # 04 followed immediately by injection of various dsRNAs as shown. Haemolymph pooled from three shrimp was used as a source of RNA and data are expressed as MoV RNA copies ng "1 total RNA. Bars indicate SEM between samples from the duplicate groups.
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cumulative mortalities were recorded until mortalities stabilized at 20 days. As shown in Fig. 4 , treatment with dsRNA-luc resulted in no protection against a low-dose challenge with the mixed virus inoculum. However, treatment with dsRNA-GAVRdRp delayed the onset of mortalities and the cumulative mortality rate at 20 days p.i. of 48 % was significantly lower (P,0.001) than in either the experimentally infected control group or the group treated with dsRNA-luc.
RNAi inhibition of MoV infection
Groups of 20 healthy juvenile P. monodon were injected with inoculum # 06 and then injected immediately with (i) dsRNA-luc, (ii) dsRNA-GAVRdRp, (iii) dsRNA corresponding to sequences in the MoV L RNA segment encoding the RdRp (dsRNA-MoVRdRp) or (iv) a mixture of dsRNAGAVRdRp and dsRNA-MoVRdRp. Cumulative mortalities were recorded for 21 days, and at 3, 6 and 9 days p.i. gill tissue was collected from shrimp from each group and GAV and MoV genetic loads were determined by qRT-PCR.
In groups treated with dsRNA-GAVRdRp or the mixture of dsRNA-GAVRdRp and dsRNA-MoVRdRp, the onset of mortalities was delayed significantly compared with the untreated control group (P,0.001), with median survival in each case increasing from 10 to 20 days p.i. (Fig. 5a ). However, in groups treated with either dsRNA-luc or dsRNA-MoVRdRp, median survival was not significantly different from the untreated control group (P,0.001). As shown in Fig. 5(b) , at 3 days p.i., GAV genetic loads in the groups treated with dsRNA-GAVRdRp or the mixture of dsRNA-GAVRdRp and dsRNA-MoVRdRp were significantly lower than in the virus-infection control group (P,0.001), but GAV genetic loads in groups treated with dsRNA-luc or dsRNA-MoVRdRp were not significantly different from the controls (P.0.05). At 6 days p.i., the GAV genetic loads in groups treated with dsRNAGAVRdRp or the mixture of dsRNA-GAVRdRp and dsRNA-MoVRdRp remained significantly lower (P,0.005) than the virus-injection control. However, at 9 days p.i. GAV genetic loads in the groups treated with dsRNA-GAVRdRp or the mixture of dsRNA-GAVRdRp and dsRNAMoVRdRp were significantly higher (P,0.05) than in the same treatment groups at 6 days p.i. and were no longer significantly different (P.0.05) from the virus-injection control.
As shown in Fig. 5(c) , MoV infection was inhibited very effectively by dsRNA-MoVRdRp targeted to L RNA segment of MoV. At 3 days p.i., MoV genetic loads were significantly lower in the two infected groups treated with dsRNA-MoVRdRp or the mixture of dsRNA-GAVRdRp and dsRNA-MoVRdRp than in the mixed virus-injection control group (P,0.05). The MoV genetic loads in these groups remained low at 6 and 9 days p.i. and were not significantly different from the MoV genetic loads in unchallenged shrimp treated with saline. MoV genetic loads in experimentally infected shrimp following treatment with dsRNA-luc or with dsRNA-GAVRdRp were not significantly different from the mixed virus-injection control group (P.0.05).
DISCUSSION
Persistent viral infections occur commonly in wild and farmed populations of healthy shrimp, sometimes involving simultaneous co-infection with multiple pathogens (Flegel et al., 2004; Lo et al., 1997; Manivannan et al., 2002; Natividad et al., 2006) . For some viruses, such as white spot syndrome virus, disease outbreaks appear to result from the amplification of viral loads in response to environmental stimuli such as stress or shifts in temperature or salinity (Joseph & Philip, 2007; Peng et al., 1998; Rahman et al., 2006; Vidal et al., 2001) . For other viruses, the prevalence of persistent infections may be very high without any recorded evidence of disease (Sittidilokratna et al., 2009b; Wijegoonawardane et al., 2008) . In healthy P. monodon collected from eastern Australia, GAV and MoV infections have each been reported at a prevalence approaching 100 % (Cowley et al., 2005a; Walker et al., 2001) and it has been difficult to identify shrimp, for either experimental infection or virus isolation, that can be assumed to be virus-free or infected with only one or other of these viruses. Furthermore, as each virus has been detected in the tissues of P. monodon shrimp collected from MCMS outbreaks on farms (Cowley et al., 2005a, b; Spann et al., 1997; Walker et al., 2001 ), it has not been possible to determine with any confidence which of these viruses is the cause of disease, or if both may be required to induce mortalities.
Two lines of evidence presented in this paper indicate that GAV, but not MoV, is the disease agent in P. monodon shrimp. Firstly, apparently healthy shrimp used in the first experimental infection harboured a very high level of preexisting MoV infection (mean viral genetic load .10 9 RNA copies ng 21 total RNA) and this did not increase significantly following lethal challenge with the mixed virus inoculum. In contrast, the pre-existing level of GAV infection was low (mean viral genetic load~10 5 RNA Fig. 4 . Cumulative mortality of groups of P. monodon shrimp injected either with 0.9 % NaCl or a 1 : 3 dilution of inoculum # 06 (virus) followed immediately by injection the dsRNAs dsRNA-luc or dsRNA-GAV RdRp. Bars indicate SEM between duplicate groups of shrimp.
copies ng 21 total RNA), but increased .10 4 -fold following experimental challenge to reach a level in moribund shrimp that was similar to MoV. Secondly, in RNAi experiments, dsRNA targeting the GAV RdRp or helicase domains of ORF1b reduced GAV genetic loads and caused a significant delay in the onset of mortalities following challenge; at a lower viral challenge dose, dsRNA targeting the GAV RdRp domain also caused a significant increase in the survival rate. In contrast, dsRNA targeting the MoV RdRp was highly effective in reducing MoV genetic loads but caused no delay in the onset of mortalities and had no effect on survival. Furthermore, simultaneous inhibition of both GAV and MoV replication by simultaneous treatment with dsRNA targeting each viral RdRp was no more effective in delaying or preventing mortalities than targeting the GAV RdRp alone. Together, these data indicate that mortalities in P. monodon shrimp result from elevated GAV genetic loads and that very high MoV genetic loads can be tolerated in the absence of disease. Furthermore, inhibition of GAV infection alone was sufficient to delay or prevent mortalities, and co-infection with MoV did not increase susceptibility to GAV-induced disease. Nevertheless, a high prevalence of MoV infection and progressively increasing viral genetic loads have been associated with poor survival in pond-reared kuruma shrimp (Penaeus japonicus), a species in which GAV infection does not occur naturally (Cowley et al., 2005b; Sellars et al., 2006) . Therefore, although only GAV appears to be pathogenic in P. monodon, we cannot exclude the possibility that MoV is pathogenic in other shrimp or crustacean species. As the viruses used in this study were derived from a single MCMS outbreak, we also cannot exclude the possibility that other more virulent strains of MoV may exist.
The NSs proteins encoded in the S RNA segment of several arthropod-borne bunyaviruses of mammals and plants have been shown to function as suppressors of RNAi (Soldan et al., 2005; Takeda et al., 2002) . Although larger than mammalian bunyavirus NSs proteins, MoV NSs2 is similar in size to the NSs protein of tomato spotted wilt bunyavirus which suppresses post-transcriptional gene silencing in plants and in tick cells in culture (Cowley et al., 2005b; De Haan et al., 1989; Garcia et al., 2006; Takeda et al., 2002) , and it was considered possible that it may have a similar MoV genetic loads determined by qRT-PCR in P. monodon shrimp groups at 3, 6, 9, 13 and 20 days p.i. following injection with 0.9 % NaCl or a 1 : 3 dilution of inoculum # 06 followed immediately by injection of various dsRNAs as indicated. Gill tissue pooled from three shrimp was used as a source of RNA and data are expressed as MoV RNA copies ng "1 total RNA. Bars indicate SEM between samples from the duplicate groups. For each treatment, sampling time points are shown in sequential order from left to right. Time points at which insufficient shrimp remained alive for sampling are indicated (X). function in shrimp. If so, silencing of MoV NSs2 expression may allow more effective dsRNA-mediated silencing of other viral genes. However, there were no significant differences in the rate of onset of mortalities, survival rate, or GAV or MoV genetic loads following treatment with dsRNA targeting the GAV helicase domain alone or simultaneous treatment with dsRNAs targeting the GAV helicase domain and MoV NSs2 gene. More studies would be needed to evaluate the possible role of MoV NSs2 as an RNAi suppressor in a natural MoV infection. Some bunyavirus NSs proteins show sequence similarity to Reaper, a proapoptotic protein from Drosophila, and have also been shown to inhibit translation and induce apoptosis (Coló n- Ramos et al., 2003) .
Previous studies have shown that YHV replication in P. monodon shrimp can be inhibited very effectively by injection of dsRNA targeting the 3C-like protease (3CLP) domain in ORF1a (Tirasophon et al., 2007; Yodmuang et al., 2006) and in shrimp cells cultured in vitro by transfection of dsRNAs targeting the 3CLP domain, or the RdRp or helicase domains in ORF1b (Tirasophon et al., 2005) . In shrimp, injection of 25 mg 3CLP dsRNA up to 5 days prior to lethal viral challenge injection resulted in complete inhibition of mortalities and dsRNA injection 3 h post-challenge resulted in undetectable viral genetic loads and survival rates similar to unchallenged control groups. In the experiments reported here, injection of shrimp with 5 mg RdRp or helicase dsRNA at the time of challenge was less effective in inhibiting GAV infection, resulting only in a delay in the onset of mortalities under high-dose challenge (undiluted stock; Fig. 3 ) and partial inhibition of mortalities under challenge with 1 : 3 dilution of the stock inoculum (Fig. 4) , corresponding approximately to the LD 50 (see Fig. 2 ). However, as reported previously, GAV is far less virulent than YHV for which the LD 50 is typically 10 8 -to 10 9 -fold lower in inocula containing equivalent viral genetic loads (Sittidilokratna et al., 2009a; Wijegoonawardane et al., 2009) . Consequently, YHV lethal challenge experiments in which very effective RNAiinduced inhibition of infection was observed employed a virus dose~10 5 -fold lower than was possible for GAV (Yodmuang et al., 2006) . It is likely that the very high dose required for lethal GAV challenge overwhelmed the RNAi pathway, limiting the effectiveness of the antiviral response.
Previous studies have also demonstrated that dsRNA can induce non-sequence-specific inhibition of viral infection in shrimp (Robalino et al., 2004 (Robalino et al., , 2005 Tirasophon et al., 2005) . However, this effect is somewhat less potent than sequence-specific inhibition by RNAi and has been demonstrated only when the dose of virus is very low (e.g. 4610
28 dilution of infected tissue extract for WSSV; 10
25
-10 27 dilution of tissue extract for YHV). Robalino et al. (2005) also demonstrated that this effect is overwhelmed by a high-dose challenge. The very high dose of the mixed virus inocula used by necessity in our studies would therefore also account for the absence of non-specific inhibition of MoV or GAV infection by GFP dsRNA.
It was also of some interest that the relative GAV and MoV genetic loads in the two challenge inocula ( # 04 and # 06) used in this study differed markedly, even though each was prepared from the same batch of stock virus. Pre-existing levels of GAV and MoV in the healthy shrimp used to prepare the inocula may have influenced the final genetic loads. However, it is also possible that the viruses compete during mixed infection as the GAV genetic load was low when the MoV genetic load was very high (inoculum # 04; Table 1 ) and higher when the MoV genetic load was quite low (inoculum #06; Table 2 ). It has been reported previously that the tissue distribution of MoV in moribund shrimp is very similar to that of GAV (Cowley et al., 2005b) and there is evidence of MoV and GAV virions in close proximity in the same cells of moribund P. monodon (Cowley et al., 2005a) . The tissue distribution of GAV in acutely infected P. monodon has also been reported to be similar to that of YHV (Spann et al., 1997) . Further work is required to identify the factors that determine why there are significant differences in virulence and pathogenicity of these three shrimp viruses.
METHODS
Shrimp for experimental infection. P. monodon shrimp were obtained from commercial farms in South-east Queensland, Australia, and stocked in sea water in 200 l tanks, each fitted with an individual filter system (Eheim), and maintained at 23-27 uC.
Virus inocula. Virus inocula containing both GAV and MoV were prepared as described previously (Cowley et al., 2005b; Rajendran et al., 2006; Spann et al., 2000) with some modifications. Four heads of infected shrimp were thawed on ice and the carapace, mouth parts and other cuticulate material were removed. The remaining tissue was diluted in 6 vols of cold shrimp salt solution (450 mM NaCl, 10 mM KCl and 10 mM HEPES, pH 7.3), homogenized using an Ultra-Turrax tissue grinder (Staufen), transferred to sterile SW28 tubes (Beckman) and centrifuged at 2500 r.p.m. in a SW32 rotor (Beckman) for 5 min at 5 uC. The supernatant was then transferred to fresh sterile SW28 tubes and centrifuged at 10000 r.p.m. for 20 min at 5 uC. The supernatant fraction was passed through a 0.45 mm filter and stored in 1.5 ml aliquots at 280 uC. Two inocula (#04 and #06) were prepared from shrimp injected with the same source stock of virus that derived from shrimp collected from a disease outbreak at a farm in Queensland, Australia, in 1996 (Spann et al., 1997) . Inocula were thawed and passed through a 0.22 mm filter prior to injection. dsRNA synthesis. dsRNAs were synthesized from DNA templates amplified by PCR using primers containing a 59-terminal T7 RNA polymerase-binding site (T7seq) (Supplementary Table S1 , available in JGV Online). For firefly luciferase, the plasmid pGL3-basic (Promega) DNA was amplified using primers Luc-500-FW and Luc-500-RV. For GAV helicase and RdRp sequences, cDNA generated from gill tissue total RNA from infected shrimp was amplified using primers GAV-hel-856-FW and GAV-hel-856-RV, and primers GAV-RdRp-892-FW and GAV-RdRp-892-RV, respectively. For MoV RdRp and NSs2 sequences, cDNA to the same total RNA preparation was amplified using primers MoV-RdRp-632-FW and MoV-RdRp-632-RV, and primers MoVNSs2-739-FW and MoV-NSs2-739-RV, respectively. Each PCR (50 ml) contained 10-500 ng DNA, 5 ml 106 MgCl 2 -free reaction buffer, 3 ml 25 mM MgCl 2 , 1 ml 10 mM dNTP mix, 0.2 ml Taq DNA polymerase (Promega) and 1.5 ml 10 nM stock of each primer. Thermal cycling conditions were 94 uC for 3 min, 30 cycles of 94 uC for 1 min, 52 uC for 50 s and 72 uC for 50 s, followed by 72 uC for 7 min. PCRamplified DNA was purified using the PCR MinElute kit (Qiagen) and used as a template for RNA synthesis using the MEGAscript T7 transcription kit (Ambion). RNA clean-up was performed using the MEGAclear kit (Ambion) and dsRNA was generated by annealing at 65 uC for 30 min followed by slow cooling to room temperature. The dsRNA was analysed by electrophoresis in a 1 % agarose gel to confirm the size and stored at 280 uC.
Experimental infection of shrimp. P. monodon shrimp (3-4 g) were infected by intramuscular injection of 50 ml of virus inoculum into the third abdominal segment. To assess RNAi effects, shrimp were similarly injected immediately following infection with 5 mg dsRNA in 50 ml 0.9 % NaCl. Control shrimp were similarly injected with 0.9 % NaCl to assess non-specific effects of injection. All treatments were performed in duplicate using 10-20 shrimp per group and each experiment was repeated in an independent trial. Mortalities were recorded daily following injection. During experimental infections, all shrimp were maintained in individual cages to avoid cannibalism.
Sample collection. Samples of gill tissue and haemolymph were collected from three shrimp from each experimental tank. Gill tissues were analysed individually but haemolymph samples from each group of three shrimp were pooled. Haemolymph was collected by the method described by de la Vega et al. (2004) with some modifications. Haemolymph (~200 ml) was collected into a 1 ml syringe (26 gauge needle) containing 200 ml ice-cold RNase-free (DEPC-treated) anti-coagulant solution (100 mM glucose, 30 mM tri-sodium citrate, 26 mM citric acid, 510 mM NaCl and 10 mM EDTA pH 4.6) (Vargas-Albores et al., 1993) . Samples were snap-frozen in dry ice and stored at 280 uC.
RNA extraction and cDNA synthesis. Total RNA was extracted from 50 ml of virus inocula, from gill tissue (~75 mg) or haemocytes pelleted briefly 10 000 g from 100 ml of pooled haemolymph. Tissue was homogenized in 750 ml TRIzol reagent (Invitrogen) using a Savant FastPrep FP120 beater and RNA was extracted according to the manufacturer's instructions. RNA was resuspended in 25 ml DEPC water, quantified by spectrophotometry (A 260 ) and stored at 280 uC. Contaminating DNA was removed using the DNA-free kit (Ambion) according to the manufacturer's instructions. cDNA was synthesized from 1 mg RNA using random hexamers and Superscript III First Strand Synthesis System (Invitrogen) according to the manufacturer's instructions.
Quantitative PCR. Viral genetic loads in inocula ( # 04 and # 06) and gill tissues were assessed using qRT-PCR. qRT-PCR (25 ml) used 1 ml 1 : 10 dilution of cDNA, the SYBR Green PCR Master Mix (PE Applied Biosystems) and 2.25 mM each primer. Thermal cycling (10 min at 95 uC, 40 cycles of 15 s at 95 uC and 1 min at 60 uC) was performed using the ABI Prism 7700 Sequence Detection System (PE Applied Biosystems). GAV RNA was detected using the primers GAVQPF1 and GAVQPR1 reported by de la Vega et al. (2004) and MoV M segment RNA was detected using the primers MoVQPF1 and MoVQPR1 reported by Rajendran et al. (2006) . All reactions were run in triplicate. Absolute quantification of numbers of GAV and MoV RNA copies ng 21 total RNA was determined from the linear regression of a standard curve generated from cDNA prepared in 10-fold serial dilutions of synthetic RNA templates.
Statistical analysis. Cumulative mortality curves were analysed using the Kaplan-Meier survival analysis and logrank tests. ANOVA and Tukey's multiple comparison test were used for the numerical data.
